Moderna
MRNA
#290
Rank
S$101.78 B
Marketcap
S$251.55
Share price
-2.17%
Change (1 day)
695.76%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2026 (TTM): S-$10.28

According to Moderna 's latest financial reports the company's current EPS (TTM) is S-$10.31. In 2025 the company made an earnings per share (EPS) of S-$9.38 an increase over its 2024 EPS that were of S-$11.97.

EPS history for Moderna from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$10.289.65%
2025S-$9.38-21.66%
2024S-$11.97-25.04%
2023S-$15.97-158.62%
2022S$27.24-30.25%
2021S$39.06-1660.82%
2020S-$2.5025.32%
2019S-$2.0036.87%
2018S-$1.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-183.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-165.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$1.28-112.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
S-$0.94-90.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S-$2.62-74.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$25.55-347.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
S-$4.30-58.32%๐Ÿ‡บ๐Ÿ‡ธ USA